Guardian Pharmacy Services (NYSE:GRDN) Sets New 12-Month High – Here’s What Happened

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) hit a new 52-week high during trading on Thursday . The stock traded as high as $42.48 and last traded at $42.0220, with a volume of 412637 shares. The stock had previously closed at $41.83.

Wall Street Analysts Forecast Growth

GRDN has been the topic of a number of recent research reports. Oppenheimer lifted their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Zacks Research cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $41.33.

Guardian Pharmacy Services Stock Up 0.5%

The business has a 50-day simple moving average of $38.01 and a two-hundred day simple moving average of $33.91. The stock has a market capitalization of $2.09 billion, a P/E ratio of 50.63, a PEG ratio of 2.74 and a beta of 0.08.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. The company had revenue of $336.60 million during the quarter, compared to analysts’ expectations of $329.89 million. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business’s revenue was up 2.2% on a year-over-year basis. During the same period last year, the business earned $0.22 earnings per share. On average, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, insider Fred Burke sold 671,432 shares of the company’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $29.68, for a total transaction of $19,928,101.76. Following the sale, the insider directly owned 840,413 shares of the company’s stock, valued at approximately $24,943,457.84. This represents a 44.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas J. Salentine, Jr. sold 3,570,677 shares of Guardian Pharmacy Services stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $29.68, for a total transaction of $105,977,693.36. Following the completion of the transaction, the director owned 4,469,316 shares of the company’s stock, valued at $132,649,298.88. This trade represents a 44.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 9,726,405 shares of company stock valued at $288,679,700. 32.96% of the stock is owned by company insiders.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors have recently bought and sold shares of the business. Ameritas Investment Partners Inc. grew its holdings in shares of Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Guardian Pharmacy Services during the 2nd quarter worth about $43,000. Strs Ohio bought a new stake in Guardian Pharmacy Services during the 4th quarter worth about $75,000. Clearstead Advisors LLC increased its position in Guardian Pharmacy Services by 196.3% in the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after acquiring an additional 1,741 shares in the last quarter. Finally, State of Wyoming acquired a new stake in Guardian Pharmacy Services in the 2nd quarter valued at about $58,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.